Stockscreener 앱 받기
7.11
7.42%
-0.57
전일 마감가:
$7.68
열려 있는:
$7.64
하루 거래량:
132.46K
Relative Volume:
0.86
시가총액:
$61.65M
수익:
$137.27M
순이익/손실:
$-123.57M
주가수익비율:
-0.6493
EPS:
-10.95
순현금흐름:
$-102.89M
1주 성능:
+12.86%
1개월 성능:
+72.15%
6개월 성능:
-14.85%
1년 성능:
-38.51%
1일 변동 폭
$7.07
$7.721
1주일 범위
$6.10
$8.15
52주 변동 폭
$3.51
$16.95
Karyopharm Therapeutics Inc Stock (KPTI) Company Profile
명칭
Karyopharm Therapeutics Inc
전화
617-658-0600
주소
85 WELLS AVENUE, NEWTON, MA
KPTI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KPTI
Karyopharm Therapeutics Inc
|
7.11 | 66.60M | 137.27M | -123.57M | -102.89M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Karyopharm Therapeutics Inc Stock (KPTI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-16 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-07-11 | 재개 | H.C. Wainwright | Buy |
| 2023-01-19 | 개시 | Piper Sandler | Overweight |
| 2022-11-04 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-02-09 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-11-19 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-08-06 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-08-06 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-07-02 | 개시 | Morgan Stanley | Overweight |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2020-01-17 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2019-07-23 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-07-05 | 재확인 | H.C. Wainwright | Buy |
| 2019-07-05 | 재확인 | Robert W. Baird | Outperform |
| 2019-03-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-02-28 | 재확인 | BofA/Merrill | Underperform |
| 2019-02-27 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-01-03 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2018-12-03 | 개시 | B. Riley FBR | Buy |
| 2018-11-09 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2018-05-24 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2018-04-02 | 재개 | Leerink Partners | Outperform |
| 2017-11-15 | 재개 | H.C. Wainwright | Buy |
| 2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
| 2016-09-08 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-08-18 | 개시 | H.C. Wainwright | Buy |
| 2016-06-28 | 개시 | Robert W. Baird | Outperform |
모두보기
Karyopharm Therapeutics Inc 주식(KPTI)의 최신 뉴스
Can Karyopharm Therapeutics Inc. hit a new high this monthChart Signals & High Win Rate Trade Alerts - Newser
Multi factor analysis applied to Karyopharm Therapeutics Inc.July 2025 Drop Watch & Daily Stock Trend Reports - Newser
How to read the order book for Karyopharm Therapeutics Inc.Market Growth Review & Detailed Earnings Play Strategies - Newser
What machine learning models say about Karyopharm Therapeutics Inc.Market Growth Report & Pattern Based Trade Signal System - Newser
Can you recover from losses in Karyopharm Therapeutics Inc.2025 Breakouts & Breakdowns & Safe Entry Zone Tips - Newser
Using AI based signals to follow Karyopharm Therapeutics Inc.Dividend Hike & Expert Approved Momentum Trade Ideas - Newser
How to use a screener to detect Karyopharm Therapeutics Inc. breakoutsJuly 2025 Summary & Precise Swing Trade Entry Alerts - Newser
Analyzing Karyopharm Therapeutics Inc. with multi timeframe chartsQuarterly Portfolio Summary & Weekly High Return Stock Opportunities - Newser
Candlestick signals on Karyopharm Therapeutics Inc. stock todayQuarterly Market Review & Real-Time Stock Price Movement Reports - Newser
Karyopharm Therapeutics Inc. stock prediction for this weekTrade Volume Report & Advanced Swing Trade Entry Plans - Newser
What momentum shifts mean for Karyopharm Therapeutics Inc.2025 Biggest Moves & Step-by-Step Swing Trade Plans - Newser
Will Karyopharm Therapeutics Inc. stock go up soon2025 Market Outlook & Long-Term Safe Return Strategies - Newser
What high frequency data says about Karyopharm Therapeutics Inc.Market Volume Summary & Consistent Return Investment Signals - Newser
Is Karyopharm Therapeutics Inc. trending in predictive chart modelsPortfolio Gains Summary & Free Community Supported Trade Ideas - Newser
Is a relief rally coming for Karyopharm Therapeutics Inc. holdersPortfolio Risk Report & Safe Entry Trade Signal Reports - Newser
Using flow based indicators on Karyopharm Therapeutics Inc.July 2025 Rallies & Safe Capital Allocation Plans - Newser
What data driven models say about Karyopharm Therapeutics Inc.’s future2025 Sector Review & Low Risk High Reward Ideas - Newser
Is Karyopharm Therapeutics Inc. benefiting from innovation trendsWeekly Trade Report & Safe Capital Growth Tips - sundaytimes.kr
Strategies to average down on Karyopharm Therapeutics Inc.Gap Down & Entry and Exit Point Strategies - Newser
Trend analysis for Karyopharm Therapeutics Inc. this weekDollar Strength & Safe Swing Trade Setup Alerts - Newser
Has Karyopharm Therapeutics Inc. found a price floorJuly 2025 Final Week & Low Drawdown Trading Strategies - Newser
Published on: 2025-08-28 12:10:43 - Newser
Will breakout in Karyopharm Therapeutics Inc. lead to full recoveryJuly 2025 Fed Impact & Growth Focused Entry Point Reports - Newser
How moving averages guide Karyopharm Therapeutics Inc. trading2025 Market Trends & Detailed Earnings Play Strategies - Newser
Published on: 2025-08-27 13:27:39 - Newser
Karyopharm Therapeutics Inc (KPTI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
1.09%
자본화:
|
볼륨(24시간):